VCAN and asthma: More recent studies have demonstrated that drugs used in the treatment of asthma including formoterol, a long acting β2-adrenergic agonist, and budesonide, a glucocorticoid steroid, could decrease protein levels of a number of proteoglycans including versican in airway SMCs and human lung fibroblasts [127,128].